Computational modeling of biologically active molecules using NMR spectra

Drug Discovery Today

Volumn 11, Issue 9-10, 2006, Pages 429-435

  Beger, Richard D ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; PENICILLIN G;

ANTIBACTERIAL ACTIVITY; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; INFORMATION; METHODOLOGY; MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLLUTANT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK ASSESSMENT; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

ANTI-BACTERIAL AGENTS; BINDING SITES; CARBON ISOTOPES; CEPHALOSPORINS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; ESTRADIOL; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; PROTEIN CONFORMATION; PROTEINS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33646101692     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2006.03.014     Document Type: Review

References (53)

1. Bursi R., et al. Comparative spectra analysis (CoSA): Spectra as three-dimensional molecular descriptors for the prediction of biological activities. J. Chem. Inf. Comput. Sci. 39 (1999) 861-867
2. 13C NMR data. J. Chem. Inf. Comput. Sci. 41 (2001) 1322-1329
3. 13C NMR spectra. Environ. Toxicol. Chem. 22 (2003) 501-509
4. 13C NMR, infrared absorption and EI mass spectrometric data models of the monodechlorination of chlorobenzenes, chlorophenols, and chloroanilines. J. Chem. Inf. Comput. Sci. 40 (2000) 1449-1455
5. 13C NMR quantitative spectrometric data-activity relationship (QSDAR) models to the aromatase enzyme. J. Chem. Inf. Comput. Sci. 41 (2001) 1360-1366
6. 13C NMR data. J. Chem. Inf. Comput. Sci. 41 (2001) 1322-1329
7. Jaiswal M., and Khadikar P. QSAR study on (13)C NMR chemical shifts on carbinol carbon atoms. Bioorg. Med. Chem. 12 (2004) 1793-1798
8. Vanderhoeven S.J., et al. Nuclear magnetic resonance (NMR) and quantitative structure-activity relationship (QSAR) studies on the transacylation reactivity of model 1beta-O-acyl glucuronides. II: QSAR modeling of the reaction using both computational and experimental NMR parameters. Xenobiotica 34 (2004) 889-900
9. Khadikar P.V., et al. Novel use of chemical shift in NMR as molecular descriptor: a first report on modeling carbonic anhydrase inhibitor activity and related parameters. Bioorg. Med. Chem Lett. 15 (2005) 931-936
10. Latosinska J.N. Nuclear quadrupole resonance spectroscopy in studies of biological active molecular systems - a review. J. Pharm. Biomed. Anal. 38 (2005) 577-587
11. Cramer R.D., et al. Cross-validation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant. Struct.-. Quant. Struct. Act. Relat. 7 (1988) 18-25
12. Cramer R.D., et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 110 (1988) 5959-5967
13. Marshall G.R., and Cramer R.D. Three-dimensional structure-activity relationships. Trends Pharmacol. Sci. 9 (1988) 285-289
14. Kellogg, et al. E-state fields: applications to 3D QSAR. J. Comput. Aided Mol. Des. 10 (1996) 513-520
15. Fang H., et al. Quantitative comparison of in vitro assays for estrogenic assays. Environ. Health Prospect 139 (1998) 723-729
16. Bradbury S.P. Quantitative structure-activity relationship and ecological risk assessment: an overview of predictive aquatic toxicology research. Toxicol. Lett. 79 (1995) 229-237
17. Pei J., et al. Improving the quality of 3D-QSAR by using flexible-ligand receptor models. J. Chem. Inf. Model 45 (2005) 1920-1933
18. De Gregorio, et al. QSAR modeling with electrotopological state indices: Corticosteroids. J. Comput. Aided Mol. Des. 2 (1988) 557-561
19. Hopfinger A.J., et al. Construction of 3D-QSAR models using 4D-QSAR analysis formalism. J. Am. Chem. Soc. 119 (1997) 10509-10524
20. Senese C.L., et al. 4D-fingerprints, universal QSAR and QSPR descriptors. J. Chem. Inf. Comput. Sci. 44 (2004) 1526-1539
21. Tong W., et al. QSAR models for binding of estrogenic compounds to estrogen receptor α and β subtypes. Endocrinology 138 (1997) 4022-4025
22. Shi L.M., et al. QSAR models using a large diverse set of estrogens. J. Chem. Inf. Comput. Sci. 41 (2001) 186-195
23. Katritzky A.R., et al. Correlation of boiling points with molecular structure. 1. A training set of 298 diverse organics and a test set of 9 simple inorganics. J. Phys. Chem. 100 (1996) 10400-10407
24. Fujita T., et al. A new substituent constant, π, derived from partition coefficient. J. Am. Chem. Soc. 86 (1964) 5175-5180
25. Klopman G. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Am. Chem. Soc. 106 (1984) 7315-7321
26. Klopman G. MULTICASE1. A hierarchial computer automated structure evaluation program. Quant. Struct. Act. Rel. 11 (1992) 176-184
27. Good A.C., et al. Structure-activity relationships from molecular similarity matrices. J. Med. Chem. 36 (1993) 433-438
28. Bradbury S.P. Quantitative structure-activity relationship and ecological risk assessment: an overview of predictive aquatic toxicology research. Toxicol Letts 79 (1995) 229-237
29. De Dios A.C., et al. Secondary and tertiary structural effects on protein NMR chemical shifts: an ab initio approach. Science 260 (1993) 1491-1496
30. Cornilescu G., et al. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13 (1999) 289-302
31. Beger R.D., and Bolton P.H. Protein φ{symbol} and ψ dihedral restraints determined from multidimensional hypersurface correlations of backbone chemical shifts and their use in the determination of protein tertiary structures. J. Biomol. NMR 10 (1997) 129-142
32. Wishart D.S., and Sykes B.D. Chemical shifts as a tool for structure determination. Methods Enzymol. 239 (1994) 363-392
33. Emsley J.W., et al. High Resolution Nuclear Magnetic Resonance 1 (1965), Pergamon Press pp. 1-287
34. 13C NMR quantitative spectrometric data-activity relationship (QSDAR) models of steroid binding to the corticosteroid binding globulin. J. Comput. Aided Mol. Des. 15 (2001) 659-669
35. Beger R.D., et al. Developing comparative structural connectivity spectra analysis (CoSCoSA) models of steroid binding to the corticosteroid binding globulin. J. Chem. Inf. Comput. Sci. 42 (2002) 1123-1131
36. Bax A., and Grzesiek S. Methodological advances in protein NMR. Acc. Chem. Res. 26 (1993) 131-138
37. Aue W.P., et al. Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J. Chem. Phys. 64 (1976) 2229-2246
38. Bodenhausen G., and Ruben D.J. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett. 69 (1980) 185-189
39. Bax A., et al. Sensitivity-enhanced correlation of 15N and 1H chemical shifts in natural-abundance samples via multiple quantum coherence. J. Am. Chem. Soc. 105 (1983) 7188-7190
40. Bax A., and Summers M.F. 1H and 13C Assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J. Am. Chem. Soc. 108 (1986) 2093-2094
41. Kumar A., et al. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 95 (1980) 1-6
42. Clore G.M., et al. Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics. Biochemistry 26 (1987) 8012-8023
43. Beger R.D., et al. Combining NMR spectral and structural data to form models of polychlorinated dibenzodioxins, dibenzofurans, and biphenyls binding to the AhR. J. Comput. Aided Mol. Des. 16 (2002) 727-740
44. 13C NMR spectral data to model a diverse set of estrogens. Internet Electronic J. Mol. Design 2 (2003) 435-453
45. Beger R.D., and Wilkes J.G. Comparative structural connectivity spectra analysis (CoSCoSA) models of steroids binding to the aromatase enzyme. J. Mol. Recognit. 15 (2002) 154-162
46. Medical Economics. Physicians' Desk Reference. 54th edn (2000), Medical Economics Company
47. Zinsser H. In: Joklik W.K., Wilett H.P., et al. (Eds). Zinsser Microbiology. 19th edn (1988), Appleton & Lange 128-160
48. Beger R.D., et al. Combining NMR spectral information with associated structural features to form computationally non-intensive, rugged, and objective models of biological activity. In: Shayne C.G. (Ed). Drug Discovery Handbook Volume 1: Pharmaceutical Development and Research Handbook (2005), John Wiley & Sons Publisher 227-286
49. Grail B.M., and Payne J.W. Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, b-lactam antibiotics and antibiotic resistance mechanisms. J. Mol. Recognit. 15 (2002) 113-125
50. Compadre R.L.L., et al. A quantitative structure-activity relationship analysis of some 4-aminophenyl sulfone antibacterial agents using linear free energy and molecular modeling methods. J. Med. Chem. 30 (1987) 900-906
51. Pickett S.D., and Sternberg M.J.E. Empirical scale of side-chain conformational entropy in protein folding. J. Mol. Biol. 231 (1993) 825-839
52. Karplus M., and Kushick J.N. Method for estimating the configurational entropy of macromolecules. Macromolecules 14 (1981) 325-332
53. 13C NMR, infrared absorption and EI mass spectrometric data monodechlorination models of chlorobenzenes, chlorophenols, and chloroanilines. J. Chem. Inf. Comput. Sci. 40 (2000) 1449-1455